These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

309 related items for PubMed ID: 7639617

  • 21. Substance P and its receptors -- a potential target for novel medicines in malignant brain tumour therapies (mini-review).
    Łazarczyk M, Matyja E, Lipkowski A.
    Folia Neuropathol; 2007; 45(3):99-107. PubMed ID: 17849359
    [Abstract] [Full Text] [Related]

  • 22. Molecular recognition of tachykinin receptor selective agonists: insights from structural studies.
    Ganjiwale A, Cowsik SM.
    Mini Rev Med Chem; 2013 Dec; 13(14):2036-46. PubMed ID: 23937231
    [Abstract] [Full Text] [Related]

  • 23. Characterization of antisera specific to NK1, NK2, and NK3 neurokinin receptors and their utilization to localize receptors in the rat gastrointestinal tract.
    Grady EF, Baluk P, Böhm S, Gamp PD, Wong H, Payan DG, Ansel J, Portbury AL, Furness JB, McDonald DM, Bunnett NW.
    J Neurosci; 1996 Nov 01; 16(21):6975-86. PubMed ID: 8824334
    [Abstract] [Full Text] [Related]

  • 24. Tachykinins and tachykinin receptors: structure and activity relationships.
    Almeida TA, Rojo J, Nieto PM, Pinto FM, Hernandez M, Martín JD, Candenas ML.
    Curr Med Chem; 2004 Aug 01; 11(15):2045-81. PubMed ID: 15279567
    [Abstract] [Full Text] [Related]

  • 25. Tachykinin NK2 receptor antagonists. A patent review (2006 - 2010).
    Altamura M.
    Expert Opin Ther Pat; 2012 Jan 01; 22(1):57-77. PubMed ID: 22149761
    [Abstract] [Full Text] [Related]

  • 26. The tachykinin NK1 receptor in the brain: pharmacology and putative functions.
    Saria A.
    Eur J Pharmacol; 1999 Jun 30; 375(1-3):51-60. PubMed ID: 10443564
    [Abstract] [Full Text] [Related]

  • 27. Diversity in mammalian tachykinin peptidergic neurons: multiple peptides, receptors, and regulatory mechanisms.
    Helke CJ, Krause JE, Mantyh PW, Couture R, Bannon MJ.
    FASEB J; 1990 Apr 01; 4(6):1606-15. PubMed ID: 1969374
    [Abstract] [Full Text] [Related]

  • 28. The role of tachykinin receptor antagonists in the prevention of bronchial hyperresponsiveness, airway inflammation and cough.
    Advenier C, Lagente V, Boichot E.
    Eur Respir J; 1997 Aug 01; 10(8):1892-906. PubMed ID: 9272936
    [Abstract] [Full Text] [Related]

  • 29. Glutamate and tachykinin receptors in central sensitization of withdrawal reflexes in the decerebrated rabbit.
    Harris J, Joules C, Stanley C, Thomas P, Clarke RW.
    Exp Physiol; 2004 Mar 01; 89(2):187-98. PubMed ID: 15123548
    [Abstract] [Full Text] [Related]

  • 30. Tachykinins in the gut. Part I. Expression, release and motor function.
    Holzer P, Holzer-Petsche U.
    Pharmacol Ther; 1997 Mar 01; 73(3):173-217. PubMed ID: 9175155
    [Abstract] [Full Text] [Related]

  • 31. Sensory neuropeptides and the human lower airways: present state and future directions.
    Joos GF, Germonpre PR, Kips JC, Peleman RA, Pauwels RA.
    Eur Respir J; 1994 Jun 01; 7(6):1161-71. PubMed ID: 7925887
    [Abstract] [Full Text] [Related]

  • 32. Postnatal development of NK1, NK2, and NK3 neurokinin receptors expression in the rat retina.
    Oyamada H, Takatsuji K, Senba E, Mantyh PW, Tohyama M.
    Brain Res Dev Brain Res; 1999 Oct 20; 117(1):59-70. PubMed ID: 10536233
    [Abstract] [Full Text] [Related]

  • 33. The study of tachykinin receptors.
    Burcher E.
    Clin Exp Pharmacol Physiol; 1989 Jun 20; 16(6):539-43. PubMed ID: 2548782
    [Abstract] [Full Text] [Related]

  • 34. Tachykinins: receptor to effector.
    Khawaja AM, Rogers DF.
    Int J Biochem Cell Biol; 1996 Jul 20; 28(7):721-38. PubMed ID: 8925404
    [Abstract] [Full Text] [Related]

  • 35. Role of tachykinin NK1, NK2 and NK3 receptors in the modulation of visceral hypersensitivity in the rat.
    Gaudreau GA, Plourde V.
    Neurosci Lett; 2003 Nov 13; 351(2):59-62. PubMed ID: 14583381
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Tachykinins and tachykinin receptors: a growing family.
    Pennefather JN, Lecci A, Candenas ML, Patak E, Pinto FM, Maggi CA.
    Life Sci; 2004 Feb 06; 74(12):1445-63. PubMed ID: 14729395
    [Abstract] [Full Text] [Related]

  • 38. Neurokinin NK1 and NK3 receptors as targets for drugs to treat gastrointestinal motility disorders and pain.
    Sanger GJ.
    Br J Pharmacol; 2004 Apr 06; 141(8):1303-12. PubMed ID: 15023866
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Distinct presynaptic control of dopamine release in striosomal- and matrix-enriched areas of the rat striatum by selective agonists of NK1, NK2 and NK3 tachykinin receptors.
    Glowinski J, Kemel ML, Desban M, Gauchy C, Lavielle S, Chassaing G, Beaujouan JC, Tremblay L.
    Regul Pept; 1993 Jul 02; 46(1-2):124-8. PubMed ID: 7692480
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.